Learning objectives and Continuing Education Credits

Requirements for successful completion: The 2019 WADE Conference is approved for the following CEU credits:

  • Pre-conference, Thursday – 4.5 hours
  • Full conference- Friday and Saturday: 13 hours
  • Single day attendance:
    • Friday - 7 hours
    • Saturday - 6 hours

Participants are required to sign in, attend the full activity for each day and complete the online evaluations at the conclusion of the conference in order to receive the CEU credits. A link to the evaluations will be provided to each participant by e-mail after the conference. After completed the online evaluation(s) the certificates for CEUs will then be available for printing.

AADE is accredited by the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center and the Commission on Accreditation (ANCC), the Commission on Dietetic Registration (CDR), and the California Board of Registered Nursing (CBRN).

General Info Sheet, including Agenda, Speakers, Objectives

For more information on CEU's, see the CEU information page.

Handouts

All handouts for conference speakers will be available digitally - we will not have printed out versions available! They will be in the form of the the speaker(s)'s slide decks saved in .PDF format, with room for notes. Available soon!

Learning Objectives: Pre-Conference - Thursday, April 25, 2019

TIME

                       TITLE

SPEAKER

OBJECTIVES

12:30-2:00pm

Fad Diets & Diabetes Management: What’s the Evidence?

 

Maureen Chomko, RD, CDE

1.Discuss differences between current dietary recommendations for diabetes management & weight loss and recommendations of fad diets
2.Describe difficulties of intermittent fasting in clinical trials and the real world
3.Identify who is an appropriate candidate for a Mediterranean diet
4.Recognize preferred eating plan for diabetes prevention
5.Analyze benefits vs potential harms of ketogenic diet

2:00-3:00pm

Standards of Care for Medical Nutrition Therapy vs. Nutrition Education in DSME: What's the Difference?

 

Megan Ellison, MS, RDN, CSOWM, CDE

1. Compare and contrast differences and similarities between MNT and Nutrition Education in DSME
2. List standards of care related to nutrition & MNT in DSME
3. Recognize the collaborative roles of the RD & RN in addressing nutrition in DSME
4. Identify your scope and areas for improvement in your own practice or amongst your DSME team

3:00-5:00pm

The Future is Plants: Integrating a Whole Foods Plant-Based Diet in Diabetes Education

 

Ineke Ohajen, RD, CDE
Yami Cazorla-Lancaster, MD

1.Define a Whole Food Plant-Based Diet
2.List 3 benefits of whole plant foods
3.Recognize the basic components of a whole foods plant-based recipe

Learning Objectives: Main Conference Day 1 - Friday, April 26, 2019

TIME

TITLE/OBJECTIVES

SPEAKER

OBJECTIVES

Keynote Speaker

8am-9am

Leveraging Your Strengths: Shaping Your Future

Nancy D’Hondt, RPh, CDE, FAADE

1.Explain value-based population health as a framework for the integration of diabetes self-management services
2.Describe the vision for the domain of diabetes education and cardiometabolic conditions in future health care and delivery
3.List at least two ways that technology can enhance the health experience for the PWD and/or healthcare provider

9am-10am

Diapression: Practical Approaches to Addressing Depression in Individuals with Diabetes

Paul Ciechanowski, MD, MPH

1.Demonstrate understanding of the various ways that depression manifests in those with diabetes
2.Accurately assess depression, diabetes distress, and co-morbid anxiety among diabetes populations
3.Identify effective ways to work with healthcare teams to appropriately manage depression, diabetes distress, and anxiety

10:20am-11:20am

Navigating the Complexities of Provider-Patient Communication: A Medical Journey with Type 1 and Eating Disorders

Quinn Nystrom, MS

1.Describe what life was like when I was diagnosed with type 1 diabetes and then an eating disorder
2 Recognize the various coping stages one may go through after a diabetes diagnosis and how the Language of Diabetes played into it
3.Compare and contrast different medical professionals and the approaches they use in interacting with patients, and how those can affect one’s life care with diabetes and how they view their chronic illness
4.Describe the 5 best communication styles when talking with patients living with diabetes

Breakout 1a

11:30 – 12:30pm

Technology in diabetes care – Emerging Level

Charlotte Parsons, ARNP, BC-FNP, CDE

Chris Fisher, RD, CDE

1.Describe the role of the CDE
2.Identify pump options and their features
3.Describe the elements of basic pump set-up
4.Identify CGM (continuous glucose monitoring) options and their features and benefits
5.Define patient education opportunities using insulin pump and CGM downloads 

Breakout 1b

11:30-12:30pm

 

Technology in diabetes care – Advanced Level

Meghann Moore, RD, CDE

1.Compare and contrast the current FDA approved insulin pumps and explain upcoming advancements among these technologies
2.Compare and contrast the current FDA approved continuous glucose monitoring systems (CGMS) and explain upcoming advancements among these technologies
3.Recognize and identify the relevant insulin pump reports and their data, including blood glucose and sensor glucose patterns, and proposed therapy adjustments based on observed data
4.Recognize and identify the relevant CGM reports and their data, including sensor glucose patterns and proposed therapy adjustments based on observed data

Breakout 2a

1:30pm-2:30pm

Medication Management in Diabetes- Emerging Level

Cheyenne Newsome, PharmD, PhC, BCACP

1.Discuss mechanism of action, common side effects, contraindications, and clinical pearls for antidiabetic medications
2.Describe patient specific considerations for appropriate medication therapy for patients with type 2 diabetes
3.Given a patient case, recommend optimal anti-diabetic medications based on benefits and possible side effects

Breakout 2b

1:30pm-2:30pm

Medication Management in diabetes – Advanced level

Faaiza Alibhai, PharmD

1.Review medication management of diabetes “Back to the Future”
2.Identify target organs for MOA of diabetes medications
3.Compare and contrast 2019 AACE, ADA, and EASD guidelines
4.Recognize newer medications and implications of use
5.Describe techniques to adjust medications according to CGM data and insulin pump starts
6.Discuss the role of the CDE in medication knowledge and patient care

2:40pm-3:40pm

Clinical Inertia: How long does it take to go from 0-85?

Jennifer Okemah, MS, RD, CDE, BC-ADM

1.Define the term Clinical Inertia
2.List techniques/approaches used to help patients reach goals
3.Explore barriers of patient support within the medical team
4.Review the role of the CDE and scopes of practice to help initiate therapy changes.
5.Create an approach for recommendations
6.Review a scenario to decrease inertia

4:00pm-5:00pm

CDE Panel: A Look Back, and to The Future

Cindy Brinn, MS, RD, CD, CDE
Alison Evert, MS, RD, CDE
Dawn Jae, MS, RDN, CDE
Jayme Miller, MS, RD, CDE
Julia Kelley, ARNP, CDE, BC-ADM

1.Explain the history of the formation of CDE credential
2.Define the role of the CDE on the medical team today
3.Compare and contrast the career pathways of seasoned CDE’s with the current new CDE’s
4.Discuss avenues for two-way mentorship

Learning Objectives: Main Conference Day 2 - Saturday, April 27, 2019

TIME

TITLE

SPEAKER

OBJECTIVES

 

8:00-9:00am

Sodium Glucose Co-transporters Inhibition and Diabetic Kidney Disease

 

 

Radica Alicic, MD

1.Recognize impact of epidemics of diabetic kidney disease and importance of morbidity and mortality associated with it.
2.Describe the role of SLGTs inhibition in treatment of diabetes.
3.Review the cardiovascular and kidney outcomes of the recent clinical trials.
4.List SGTL's effects on blood pressure, weight, kidney hemodynamics
5.Recognize changes of the professional guidelines for diabetes treatment

9:00-10:00am

Cardiovascular Outcomes Trials: What does it mean for the CDE’s?

 

Carol Wysham, MD

1.Describe management of CVD and diabetes therapies prior to CVD Trials
2.Explore the history and process of CardioVascular Outcome Trials (CVOT)
3.Compare and contrast published CVOT trials
4.Identify upcoming trials
5.Define role of CDE in CV/DM management
6.Discuss implications of CVOT and role of changes made to 2019 ADA Standards of Care guidelines

10:20-11:20am

Diabetes and Low Vision: Rehabilitation, Past, Present, and Future

Tina McDonald, OD, FAAO, CDE

1. List the stages of Diabetic Retinopathy and other Ocular Complications.
2. Demonstrate familiarity with the terms and descriptions of Vision Impairment and Blindness. What is the significance of those terms?
3. Describe two reasons why the Interdisciplinary relationship between Optometrists and Diabetes Educators is important for those with Diabetes and Vision Loss.
4.List tools and adaptive techniques to help those with Diabetes and Vision Loss

11:30-12:30pm

Providers Panel Experiences with CDE’s: What Works, What Are The Challenges, Where Are We Going?

 

Carol Wysham, MD
Paul Ciechanowski, MD, MPH
John Peng, MD
William Martin, PA-C, CDE
Julia Kelley, ARNP, CDE, BC-ADM
Mary Janci, ARNP, CDE, BC-ADM

1.Explain overview of CDE history and role on medical team
2.Identify professional experiences with CDE’s
3.Discuss proposed questions to panel
4.Open mic questions from audience

Breakout 3a

1:40-2:40 pm

Effective Transition of Diabetes Care: Inpatient to Outpatient

Christiian Lewis, ARNP, BC-ADM

1.Explain the scope of the problem and importance of early integration into the diabetes management team to better prepare the patient for discharge
2.Propose strategies learned to augment the discharge process
3.Compare and contrast discharge disposition for certain high risk groups

Breakout 3b

1:40-2:40pm

Effective Transition of Diabetes Care: Pediatric to Adult

 

William Martin, PA-C, CDE

1.Define “Transition in Care"
2.Describe the need for effective transition of care to the adult world
3.Discuss challenges and barriers faced by emerging adults
4.Review overview of strategies and clinician views in transitioning care from pediatrics to adult clinic 

3:00-4:00pm

Goldstein speaker:

Back to the Future of JDRF Research

 

Derek Rapp, President & CEO of JDRF

1.Describe involvement and interest in Type 1 Diabetes and JDRF
2.Discuss role as President, CEO of JDRF International
3.Identify and recognize the needs of T1D in the community
4.Describe current research projects funded by JDRF and focus on 3 strikes
5.Explain positive role of the CDE in future of diabetes care

REGISTER  NOW